A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

NCT05780294 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Leucogen
Chemotherapy
Myelosuppression

Interventions

DRUG: 5-fu
DRUG: Lobaplatin
DRUG: Placebo
DRUG: leucogen

Sponsor

Sun Yat-sen University

Collaborators

[object Object]